Abstract
Variable rate intravenous insulin infusion (VRIII) – previously sliding scale insulin – is an established methodology to achieve normoglycaemia in hospital patients with severe hyperglycaemia. However there are several different sliding scales, even within the same hospital. This new guideline is designed for use by any healthcare professional responsible for the care of acutely unwell patients who present with hyperglycaemia – with or without a previous diagnosis of diabetes. It offers practical guidance on use of VRIII and patient transition to other glucose-lowering therapy on stabilisation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
